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Abstract: The discovery of increasing numbers of genes with overlapping 
sequences highlights the problem of expression in the context of constraining 
regulatory elements from more than one gene. This study identifies 
regulatory sequences encompassed within two genes that overlap in an 
antisense orientation at their 3′ ends. The genes encode the α-thyroid 
hormone receptor gene (TRα or NR1A1) and Rev-erbα (NR1D1). In mammals 
TRα pre-mRNAs are alternatively spliced to yield mRNAs encoding functionally 
antagonistic proteins: TRα1, an authentic thyroid hormone receptor; and 
TRα2, a non-hormone-binding variant that acts as a repressor. TRα2-specific 
splicing requires two regulatory elements that overlap with Rev-erbα 
sequences. Functional mapping of these elements reveals minimal splicing 
enhancer elements that have evolved within the constraints of the 
overlapping Rev-erbα sequence. These results provide insight into the 
evolution of regulatory elements within the context of bidirectional coding 
sequences. They also demonstrate the ability of the genetic code to 
accommodate multiple layers of information within a given sequence, an 
important property of the code recently suggested on theoretical grounds. 
Keywords: alternative splicing, exonic splicing enhancer, intronic splicing 
enhancer, antisense RNA, genetic code, exon evolution, nuclear receptor 
proteins 
Introduction 
A single genomic locus can give rise to more than one distinct 
protein product through alternative RNA splicing, alternative promoters 
and differential 3′ end processing.1 Because transcription can occur on 
either strand of the DNA, a single genomic locus can also produce 
RNAs from the opposite DNA strand, resulting in potential formation of 
complementary transcripts termed cis-encoded natural antisense 
transcripts (cis-NATs or cis-antisense RNAs).2, 3 Regulatory 
mechanisms associated with antisense transcription and alternative 
splicing are at present poorly understood. However, it is clear that the 
combination of alternative splicing and overlapping transcription 
greatly increases the complexity and information density of the human 
transcriptome.4–8 It has been estimated that upwards of 95% of 
protein-coding transcription units give rise to alternatively spliced 
mRNAs7, 9–11 and more than 70% of transcription units in the human 
genome are transcribed in both directions.5, 12, 13 
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In this study we examine requirements for alternative 
processing within the mammalian α-thyroid hormone (T3) receptor 
gene (TRα). This gene yields two alternatively spliced mRNAs that 
encode two functionally antagonistic proteins, TRα1 and TRα2.14 TRα1 
(NR1A1a) is an authentic nuclear receptor that together with the 
related receptors, TRβ1 (NR1A2a) and TRβ2 (NR1A2b), encoded by the 
TRβ gene, mediates the cellular response to T3.15 Each of these 
nuclear receptors has an N-terminal DNA-binding domain that 
recognizes T3 response elements (TREs) and a C-terminal ligand-
binding domain that binds T3 and activates T3-responsive genes. In 
contrast, TRα2 (NR1A1b) is a non-hormone-binding variant that differs 
from TRα1 in its C-terminal domain and neither binds T3 nor activates 
transcription. TRα2 is thought to modulate the response to T3 by 
dominant-negative interference with the hormone-responsive 
isoforms.14, 16 Consistent with this hypothesis, expression of TRα2 is 
developmentally regulated in many tissues, including brain, where it is 
the predominant TRα isoform.14, 17, 18 
The structure of TRα2 reflects its unique 3′ exon, which is 
located downstream of the polyadenylation site for TRα1 mRNA. This 
exon overlaps the 3′ exon of another mRNA on the opposite strand of 
the chromosome that encodes a third nuclear receptor, Rev-erbα 
(NR1D1).19, 20 Although long regarded as a ligandless orphan receptor, 
Rev-erbα has recently been shown to bind heme specifically in its 
canonical ligand-binding domain.21, 22 In the presence of this ligand, 
the interaction of Rev-erbα with co-repressors is responsive to 
physiological regulators such as nitric oxide. These results and the 
well-documented role of Rev-erbα as a component of the mammalian 
molecular clock demonstrate that Rev-erbα, like TRα1, serves as a 
critical physiological regulator.21–24 The overlap between TRα2 and 
Rev-erbα may have important consequences for the balance between 
TRα1 and TRα2, as indicated by in vivo and in vitro analysis.25–28 
Several recent studies have demonstrated that requirements for 
splicing regulatory elements constrain the coding sequence of 
alternatively spliced mRNAs.29–32 Since the overlap between the Rev-
erbα and TRα genes includes a portion of the C-terminal coding 
sequence of both genes, it seemed likely that requirements for coding 
might represent an overriding constraint that restricts regulatory 
elements for TRα2 splicing to sites outside of the overlap. Contrary to 
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this expectation, experiments reported here define two splicing 
enhancers, TR-ISE3 and ESX10, that are located within the overlap 
between TRα2 and Rev-erbα where they flank the TRα2-specific 3′ 
splice site (ss). Most notably, ESX10 maps directly to the bidirectional 
coding sequence (BCS) associated with the overlap between coding 
sequences for both TRα2 and Rev-erbα. These results provide a 
striking demonstration of the ability of the genetic code to 
accommodate multiple layers of information and raise interesting 
questions concerning the evolution of this gene overlap.33 
Results 
Sequence and structure of the TRα and Rev-erbα 
overlap 
As shown in Figure 1, TRα1 mRNA is formed by splicing exon 1 
through exon 9 whereas TRα2 mRNA is formed by splicing the 5′ end 
of exon 9 (exon 9A) to exon 10. Exon 10 overlaps the final exon of 
Rev-erbα such that the 3′ end of Rev-erbα mRNA overlaps the 3′ss of 
TRα2 mRNA and vice versa. Together the two transcription units 
occupy 34 kb on rat chromosome 10 with a 1.1 kb overlap. The 263 bp 
exon-exon overlap between TRα2 and Rev-erbα includes the 200 bp 
BCS comprising 67 codons at the C-terminus of each protein that 
share an in-phase overlap. Furthermore the poly(A) site of TRα2 mRNA 
maps within 50 bp of the final 5′ ss of Rev-erbα mRNA, and that of 
Rev-erbα mRNA maps between the poly(A) site of TRα1 and the 3′ss of 
exon 10 imposing additional constraints on this region. 
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Figure 1 Structure and processing of TRα2 mRNA. A. Schematic representation of 
the structure of the TRα and Rev-erbα genes which overlap by 1.1 kb on rat 
chromosome 10 (position 316154–338490; reference assembly RGSC v3.4). Boxes 
represent exons which are numbered for TRα, pointed boxes are 3′ terminal exons and 
horizontal lines are introns. The positions of three splicing enhancers including SEα2, 
previously described 34, TR-ISE3 and ESX10, are represented by hatched ellipses. 
Splicing of exons 9A and 10 in TRα2 mRNA is indicated by a dotted angled line. Dark 
gray shading represents coding sequences, light gray shading untranslated regions. 
The position of the minigenes cloned in pErbA is indicated by a bracket at top. Bold 
letters (B,S, X) indicate endpoints of deletions. The TRα/Rev-erbα overlap region is 
highlighted by shading. B. To-scale representation of the 1.4 kb region shaded in 
Panel A. Splicing enhancers TR-ISE3 and ESX10 are indicated by hatched ellipses. C. 
Segmented bar indicates regions defined by processing sites, base composition and 
conservation. Segments are labeled as follows: pA is poly(A) site; Rev is Rev-erbα; Cn 
and Gn denote C-rich and G-rich regions, respectively; BCS is bidirectional coding 
sequence; and 3′ UTR is the 3′ untranslated region. Single letters above bar indicate 
endpoints of deletions within minigenes. Numbers at bottom indicate sequence identity 
between rat and human. 
As a first step towards understanding constraints introduced by 
the overlap between these genes we compared the genomic sequences 
of six mammals (human, chimp, mouse, rat, dog and cow) across the 
region including the overlap between TRα2 and Rev-erbα mRNAs and 
the adjacent 3′ sequence of TRα1 mRNA (Supplementary data, Table 
S1). Although sequences throughout the region where TRα1, TRα2 and 
Rev-erbα mRNAs converge are highly conserved, local variations in 
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sequence composition and conservation reflect diverse constraints. 
Within the region highlighted in Figure 1C there are three areas of very 
high conservation, illustrated here for the rat-human alignment. These 
include a stretch of 200 bp at the 3′ end of exon 9 of TRα1 mRNA, 100 
bp upstream of the 3′ss for exon 10 in TRα2 mRNA and 300 bp at the 
5′ end of exon 10 (Table S1). Between the TRα1 poly(A) site and the 
3′ exon of TRα2 70 bp of sequence antisense the Rev-erbα poly(A) site 
are also highly conserved (96% identity). This region is flanked 
upstream and downstream by C-rich and G-rich regions (Cn and Gn, 
respectively; Figure 1C) that are less tightly conserved with numerous 
runs of three or more consecutive C or G residues. These features 
reflect multiple, overlapping requirements for transcription, processing 
and translation on one or both strands. 
The TRα2-specific 3′splice site is suboptimal 
To understand functional constraints introduced by the overlap 
with Rev-erbα and how they may relate to regulation of TRα 
expression, we examined sequences directly involved in TRα2 splicing. 
Many alternative splice sites are suboptimal in their match to 
consensus sequences and their efficiency of splicing. For example, a 
previous study showed that replacement of a single non-consensus 
nucleotide at the 5′ss of TRα2 (+5C/G) greatly increases TRα2 splicing 
28. Since the 3′ss of exon 10 is also a poor match to the consensus 
sequence, with AAG (vs. CAG) immediately preceding the splice site 
(Figure 2A), the non-consensus adenosine was replaced with cytidine 
(−3A/C) in a minigene construct, pErbAΔBS, that lacks the upstream 
SEα2 enhancer required for efficient splicing.28, 34 This single-
nucleotide substitution results in a substantial increase in splicing, 
although it is less than that seen when the +5C/G mutation is 
incorporated into the 5′ss of this construct (Figure 2B). These results 
demonstrate that both 3′ss and 5′ss are suboptimal and contribute to 
the regulation of TRα1/TRα2 mRNA levels. The lower splicing efficiency 
of the 3′ss substitution may reflect other suboptimal features of this 
site such as a non-consensus branch point (Hastings, unpublished 
result). 
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Figure 2 The TRα2-specific splice sites are suboptimal. A. Sequences of 5′ and 3′ 
splice site sequences and corresponding point mutations. B. RNase protection assays 
of TRα2-splicing of wildtype and mutant ErbAΔBS pre-mRNAs in HEK293 transfected 
cells. The control lane (C) shows cells transfected with vector plasmid express no 
detectable endogenous TRα1 or TRα2 mRNA. Structure of the ErbAΔBS minigene is 
shown at right with the position of the probe indicated by the bold line. Arrows labeled 
“U” and “S” indicate bands corresponding to unspliced and spliced RNAs, respectively, 
and % splicing is shown below each lane. Double bands in some lanes represent 
partial protection of ends of RNase trimmed probes hybridized to unspliced RNA. 
Results are representative of two independent experiments. 
Sequences at the 3′ end of the regulated intron 
enhance TRα2 mRNA splicing 
Because suboptimal splice sites often are regulated by intronic 
or exonic splicing enhancer elements (ISEs or ESEs), requirements for 
sequences adjacent to the TRα2 3′ss in splicing regulation were 
evaluated through a series of deletions upstream of the 3′ ss. Previous 
studies showed that one such splicing enhancer element, SEα2, lies 
within an 80 nt region directly downstream of the TRα1 coding 
sequence.28, 34 Here, two series of deletions in the 3′ss region were 
examined that differ in the presence or absence of the SEα2 splicing 
enhancer34, one derived from pErbAΔXS and the other from pErbAΔBS 
(Figure 3A). RNase protection assays show a dramatic stimulation of 
TRα2 splicing in RNA from the ΔBD, ΔBE and ΔBP minigenes. These 
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results demonstrate that sequences upstream of the polypyrimidine 
also contribute to TRα2 splicing efficiency (Figure 3B). A parallel 
increase was seen in splicing of transcripts ErbAΔXD, ErbAΔXE and 
ErbAΔXP compared with that of the parent construct, ErbAΔXS (Figure 
3B). As the difference in splicing observed with ErbAΔBE and ErbAΔBP 
is small relative to that between ErbAΔBS and ErbAΔBD or ErbAΔBE 
(with parallel results for the series ErbAΔXS through ErbAΔXP), we 
conclude that the sequences between site “E” and “P” in ΔBE and ΔBP 
contribute marginally to TRα2 splicing. Consequently, the ES fragment 
(present in ΔBE and ΔXE but absent in ΔBS and ΔXS) includes an 
intronic splicing enhancer which we designated TR-ISE3. 
 
Figure 3 Intronic sequences adjacent to the TRα2 3′ss are required for efficient 
splicing of TRα2 mRNA. A. Structure of ErbA minigene pre-mRNA is shown on top and 
the structures of 9 deletion constructs within the final exon of TRα2 mRNA are shown 
below. Splicing of ErbAΔBS and ErbAΔXS pre-mRNAs, has been described previously 
28. Light shading of BX fragment indicates SEα2 enhancer, dark shading sequences 
overlapping TR-ISE3. Endpoints of deletions are indicated by letters B, X, P, E, D,S 
and by inverted triangles for deletions DS-20L and DS-20R shown in panel E. Speckled 
shading indicates 300 nts of heterologous sequence in ErbAΔBS-H derived from 
lambda phage. B. RNase protection assays showing splicing of deleted pre-mRNAs 
expressed in HEK293 as in Fig. 2. Splicing of ΔBS series, lacking 5′ss proximal SEα2 
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enhancer, and ΔXS series including the SEα2 enhancer is shown 34. % Splicing 
(average of 3 experiments except for ErbA-H) and standard deviation (SD) is shown at 
bottom of figure. C. RNase protection assays showing effect of deleting 20 nts from 
either the 5′ end (-20L) and 3′ end (-20R) of the DS fragment present in ErbAΔBD as 
indicated in Panel A (inverted triangles) and Panel E. % splicing and standard 
deviation shown for 6–12 experiments. D. In vitro splicing of 32P-labeled transcripts 
following 0, 45 and 90 min incubation with HeLa cell nuclear extract. % splicing is 
representative of three experiments. E. Sequence of TR-ISE3 with downstream 
endpoints of deletions indicated with (/) and labels. Runs of 3 or more G residues are 
shown in bold. “U” and “S” indicate unspliced and spliced RNAs. 
Interestingly, the effects of SEα2 and TR-ISE3 appear additive; 
that is, the increase in splicing of transcripts in the series ErbAΔXS 
through ErbAΔXP closely matches that observed with the series 
ErbAΔBS through ErbAΔBP. When the percent splicing of ErbAΔBS is 
subtracted from the percent splicing observed with ErbAΔBD, ErbAΔBE 
and ErbAΔBP, the results are similar to those obtained by subtracting 
the percent splicing of ErbAΔXS from that for ErbAΔXD, ErbAΔXE and 
ErbAΔXP (e.g. 16%, 23% and 23% vs. 15%, 20% and 21%, 
respectively, as shown in Figure 3B). The additive effects of SEα2 and 
TR-ISE3 suggest that these two enhancers function independently of 
one another. 
Mapping of TR-ISE3 was confirmed by additional experiments. 
Deletion of 20 nts from either end of the DS fragment in ErbαΔBD (DS-
20L or DS-20R) containing the TR-ISE3 sequence in ErbAΔBD, 
decreased splicing by 40% relative to ErbAΔBD (Fig 3C). To determine 
if TR-ISE3 is active in vitro as well as in vivo a parallel series of 
transcripts were tested for their ability to undergo splicing when 
incubated in vitro with HeLa cell nuclear extract.26, 34 Transcripts 
containing sequences corresponding to ΔBD, ΔBE and ΔBP showed a 
large increase in splicing when compared to the minigene transcript 
α2-ΔBS (Figure 3D). In contrast to their in vivo expression, however, 
similar levels of splicing were observed in vitro for all three RNAs, α2-
ΔBE, α2-ΔBD and α2-ΔBP, suggesting that either only the 3′end of TR-
ISE3 is active in vitro or that the longer introns in α2-ΔBE and α2-ΔBP 
counteract the stimulatory effects of the full-length TR-ISE3 enhancer. 
Efficient TRα2 mRNA splicing requires exon 10 
sequences 
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The presence of enhancer elements at either end of the TRα2 
intron raises the question whether intronic sequences alone are 
sufficient to regulate splicing at the flanking suboptimal 5′ and 3′ 
splice sites. To assess the possible contribution of sequences within 
exon 10 to TRα2 splicing, we constructed a series of deletions within 
exon 10. First, 400 nts were deleted from exon 10 of the plasmid 
pErbAΔBE starting 31 nt downstream of the 3′ss. This deletion (ΔGM) 
removes almost half the length of exon 10, while leaving sequences 
adjacent to the splice site and poly(A) sites intact (Figure 4A). When 
expressed in HEK 293 cells the transcript ErbAΔGM was very poorly 
spliced in comparison with the parent plasmid, pErbAΔBE (Figure 4B). 
In fact, the splicing of pErbAΔGM was only slightly greater than that of 
pErbAΔBS lacking both TR-ISE3 and SEα2 (Figures 4B, 4C). Next, two 
other transcripts each containing 200 nt deletions that represented 
either half of the ΔGM deletion were similarly tested. ErbAΔRM, the 
transcript with the 3′ deletion, was spliced at almost the same level as 
a transcript with the intact exon sequence. In contrast, ErbAΔGR, the 
transcript with the 5′ deletion, showed a substantial decrease in 
splicing as shown in Figures 4B and 4C. These data suggest the 
presence of a splicing enhancer element within the fragment deleted in 
ErbAΔGR. 
 
Figure 4 Sequences within exon 10 are required for efficient TRα2 splicing. A. 
Diagram of ErbAΔBE minigene transcript showing endpoints of exon 10 deletions. B. 
RNase protection assays showing splicing of TRα2 minigene transcripts with exon 10 
deletions transfected in HEK 293 cells as described in Fig. 2. C. Quantitation of splicing 
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(average of 6 experiments except for ΔBS where n=2). D. RNase protection assays on 
transfected minigenes with sequences deleted in ErbAΔGR replaced by homologous 
sequence from antisense strand of Rev-erbβ gene (GRβ). E. Quantitation of splicing 
(average of 5–8 experiments). 
Because a variety of adventitious effects may be associated with 
deletions due to the unintended introduction of new sequence 
elements or alteration of transcript stability, the activity of the region 
encompassed by the ΔGR deletion was examined by two alternate 
approaches. First, the GR fragment (deleted in pErbAΔGR) was 
replaced in the parental construct with a size-matched sequence (GRβ) 
derived from the antisense strand of the homologous Rev-erbβ gene 
(NR1D2). Although this fragment is 63% homologous to GR from 
TRα2, the Rev-erbβ gene lacks an overlapping antisense mRNA 
comparable to TRα2 and thus is also unlikely to have a functional 
splicing enhancer on its antisense strand. The resulting construct, 
pErbAGRβ, showed low levels of splicing, only 50% that of wildtype, as 
shown in Figure 4D and 4E. This result taken together with the 
deletion analysis is consistent with the presence of an exonic splicing 
enhancer. 
To examine the role of exonic sequence elements in enhancing 
splicing of TRα2 in vitro, a series of constructs were prepared in which 
the sequence deleted in pErbAΔGR was fused to the 3′ end of pre-
mRNA derived from exons 3 and 4 from the Drosophila dsx gene but 
lacking a functional splicing enhancer.34–36 First, a 200 bp fragment 
corresponding to the GR region of exon 10 and the homologous GRβ 
antisense sequence from Rev-erbβ were compared for their ability to 
promote splicing of the truncated dsx pre-mRNA in HeLa cell nuclear 
extract. The transcript with the GR fragment derived from TRα2 (Dsx-
GR) increased splicing of Dsx pre-mRNA to a level much higher than 
the parent Dsx minigene transcript, as shown in Figures 5B and 5C. In 
contrast, dsx pre-mRNA with the GRβ sequence added was spliced at a 
very low level, similar to that of the control Dsx vector transcript (Dsx-
GRβ, Figure 5D). As a positive control, the dsx pre-mRNA with a very 
strong ASLV enhancer added35 was tested in parallel and found to 
splice at a level similar to that of Dsx-GR (Figures 5C, 5D). 
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Figure 5 Sequences within the bidirectional coding region of exon 10 promote 
splicing of dsx pre-mRNA. A. Structure of chimeric dsx transcripts. Open boxes 
represent exons 3 and 4 of Drosophila dsx pre-mRNA, shaded boxes represent added 
sequences from TRα2 exon 10 or ASLV. G100, R100 are 5′ and 3′ half of GR fragment, 
respectively. B and C. Splicing of 32P-labeled dsx pre-mRNAs in vitro. Arrows next to 
each lane indicate unspliced (U, top) and spliced (S, bottom) RNAs. D. Quantitation of 
splicing of dsx pre-mRNAs, average of 3–9 experiments. 
To further map sequences required for enhancer activity, the GR 
fragment was split into two fragments of 113 nts each, designated 
G100 and R100, from the 5′ and 3′ half, respectively, and each 
fragment was tested separately. As shown in Figure 5C, fragment 
R100 enhanced splicing of dsx pre-mRNA almost to the same level as 
the GR fragment. In contrast, the G100 fragment was much less 
efficient, as seen by the relatively high ratio of unspliced to spliced 
RNA after incubation in HeLa cell nuclear extract. Quantitation of 
splicing of Dsx-G100 in multiple splicing assays showed that only 
about 20% of this transcript was spliced in contrast to about 60% of 
Dsx-R100 (Figs. 5C and 5D). The results shown in Figures 4 and 
and5,5, taken together, demonstrate that sequences located within 
the 3′ half of the GR fragment constitute an exonic enhancer, 
designated ESX10 (exonic splicing enhancer in exon 10). 
Multiple sequences within ESX10 enhance splicing 
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Since exonic splicing enhancers are often comprised of short 
sequence elements, typically 6–9 nt in length, that correspond to 
binding sites for individual proteins,37–39 we wished to identify shorter 
elements within the R100 fragment. The length of R100 was thus 
subdivided into 6 overlapping segments, each of which was 42 
nucleotides long (with the exception of fragment“A” that was 43 nts). 
These subfragments of R100 were designated R42αA-R42αF as shown 
in Figure 6A. The ends of each fragment were staggered 14 nt apart 
such that each fragment overlapped the next by 28 nt, to minimize the 
chance of truncating active elements. Since the 3′ end of the pre-
mRNA affects the stability of the extended dsx pre-mRNA, each 
fragment was terminated with the same 5 nt sequence, AGATC, based 
on the XbaI runoff site used for transcripts derived from the plasmid 
vector, pDsx. Each of the sequences (R42αA-R42αF) was matched with 
a homologous sequence derived from the antisense strand of the Rev-
erbβ gene (R42βA-R42βF) to provide a parallel set of six controls. 
 
Figure 6 Mapping of enhancer sequences within R100 fragment. A. R100 fragment 
was subdivided into 6 overlapping fragments 42–43 nts in length, R42A R42F, as 
shown in diagram. B. and C. Splicing of 32P-labeled chimeric dsx transcripts for 90 min 
in vitro with HeLa cell nuclear extract. R42αA to R42αF fragments with positive (Dsx-
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ASLV) and negative (Dsx, vector-only) controls (B) or R42βA to R42βF fragments 
using homologous sequences from the antisense strand of Rev-erbβ (C). D. 
Quantitation of results in experiments shown in Panels B and C. Light shaded bars: 
Dsx-R42α pre-mRNAs; dark shaded bars: Dsx-R42β pre-mRNAs; speckled shading: 
controls. 
As seen in Figure 6B, each of the 42 (or 43) nt sequences 
derived from the TRα2 R100 sequence promoted splicing of dsx pre-
mRNA to approximately the same extent. Notably, the strong ASLV 
enhancer, which is almost the same length as the 42 nt ESX10 
fragments, was only slightly more active than R42αA-R42αF. In 
contrast, each of four sequences derived from R100β (R42βC through 
R42βF) showed negligible activity (Figures 6C and 6D), while the 
remaining two Rev-erbβ antisense fragments, R42βA and R42βB, 
showed much lower activity than that associated with the 
corresponding R42αA and R42αB fragments from ESX10. To test 
whether the 5 nt extension present on all the fragments might 
contribute to the observed splicing enhancer activity, R42αF was 
prepared with and without the extension. Both fragments were found 
to splice with identical efficiency (result not shown). These results 
suggest that multiple, functionally redundant enhancer elements are 
present within the R100 sequence. 
Given the configuration of the overlapping test fragments, as 
few as two enhancer elements located within the 14 nt overlaps 
between R42αA, R42αB and R42αC and between R42αD, R42αE and 
R42αF might account for the consistent enhancement observed with 
these fragments, It is more probable, however, that 3 or 4 elements 
are dispersed within the R100 region. To further evaluate the role of 
such elements a 70 nt region at the 5′ end of R100 was examined. 
This region includes the full length of fragments R42αD, R42αE and 
R42αF but entirely excludes R42αA. All possible combinations of either 
R42αF or R42βF sequence with 28 nts from αD or βD (R28αD′ and 
R28βD′) were tested for enhancer activity when fused to dsx pre-
mRNA as shown in Figure 7B. The two chimeric 70 nt fragments 
displayed intermediate activity relative to the 70 nt sequences from 
TRα or the antisense of Rev-erbα (that is R70αFαD′ > R70αFβD′> 
R70βFαD′ ≫ R70βFβD′) in proportion to the relative content of TRα 
sequence (Figure 7A). These sequences reflect the presence of 28 
substitutions (60% identity) within the 70 nt region. 
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Figure 7 Enhancer activity of sub-fragments of the exonic splicing enhancer, 
ESX10. A. Splicing of dsx pre-mRNA in vitro in HeLa cell nuclear extract showing 
enhancement with 70 nt fragments derived from the 5′ end of R100. R42αF or R42βF 
was fused to 28 nts from the 3′ end of αD or βD fragment to create R70αFαD′ 
R70αFβD′, R70βFαD′ and R70βFαD′. B. Schematic representation of transcripts shown 
in panels A and C. Open boxes are Dsx exons, light shaded boxes are TRα2 exon 10 
sequence, and hatched boxes homologous Rev-erbβ antisense sequences. C. Splicing 
of dsx-pre-mRNAs in vitro after 0, 1 and 2 h in which one or two of the three RESCUE 
elements (R1, R2 or R3) present in Dsx-R70FD′ (R123) contain the substitutions 
shown below. In Panels A and C 0,1,2 h splicing reactions are shown together with 
average percent splicing (%) and standard deviation (SD) for four experiments. D. 
Sequence of R70αFD′, R70FD′ (R123) and R70βFβD′ fragments. Positions differing in 
R70αFD′ and R70βFD′ are marked with asterisks. The sequence of R70βFD′ and 
substitutions in R70FD′ (R123) derived from R70βFD′ sequences are shown in 
lowercase. Arrows indicate the overlapping sequences R42F, R42E and R42D as well as 
the boundary (marked with “/”) between R42F and R28D′. Underlined sequences are 
three 7 nt elements, R1, R2 and R3, each comprised of two overlapping ESE-
associated hexamers according to the analysis of Fairbrother et al. 40. 
To further define the sequences requirements for enhancer 
activity, the bioinformatic approach of Fairbrother et al. 38, 40 was 
employed to identify three heptamers (R1, R2, R3; underlined in 
Figure 7D) comprised of overlapping hexamers with exonic enhancer 
activity. Interestingly, one or two of these elements are present in five 
of the six R42 fragments. Each of the heptamers is altered by two or 
three nucleotide substitutions in the antisense Rev-erbβ sequence 
(Figure 7D). When the eight substitutions present in these elements 
were introduced together into R70αFD′, splicing of the resulting 
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chimera, R70FD(R123), was inhibited more than 95% (Figure 7A). The 
effect of these substitutions introduced in R70FD(R123) is greater than 
that of a much larger number of substitutions in either R70αFβF or 
R70βFαD′, demonstrating that at least two of the elements are 
essential for the activity of ESX10. Individual and pairwise introduction 
of mutations in R1, R2 and R3 elements into the wildtype R70αFD′ 
were also analyzed. Individually, the R1 substitution showed the 
strongest effect and while R2 and R3 alone each had little effect 
(Figure 7C). However, the combination of the mutations in R1 and 
either R2 (R70FD′ (R12)) or R3 (R70FD′ (R13)) was very effective in 
blocking R70 enhancer activity and the effect on splicing of five 
substitutions in R2 and R3 was comparable to that of 11 substitutions 
in R70 αFβD′ (Figure 7C). Thus, the enhancer element represented by 
R1 acts synergistically with that represented by R2 and R3 to promote 
splicing of the heterologous Dsx transcript. 
Evolution of ESX 10 
To explore the evolution of the overlap, analysis of the region 
was extended to non-mammalian vertebrates, which lack TRα2. The 
convergent orientation and proximity of the TRα and Rev-erbα genes 
in non-mammalian vertebrates is apparent in the frog, Xenopus 
tropicalis, where neither the TRα2 coding sequences nor the 3′ ss 
specific for TRα2 mRNA are present (not shown). Within the sequence 
corresponding to the BCS, the mammalian Rev-erbα amino acid 
consensus sequence differs from that of X. tropicalis in only ten of 67 
codons (Figure 8A and 8B). Nine of these changes are clustered within 
the R100 fragment although it accounts for only a little more than half 
the length of the BCS. A total of 19 nucleotide substitutions are 
associated with these nine replacements. This pattern of clustered 
substitutions maximizes the number of base changes and the range of 
amino acid selection relative to the number of amino acid 
replacements (Figure 8B). Thus, a small number of largely 
conservative amino acid changes in the sequence of Rev-erbα is 
sufficient to accommodate both coding and splicing of TRα2. 
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Figure 8 Clustering of non-synonymous nucleotide substitutions within ESX10 in a 
non-mammalian vertebrate, lacking TRα2. A. Distribution of nucleotides substitutions 
within the amphibian sequence homologous to the bidirectional coding sequence of the 
mammalian TRα2. The sequencesα from the TRα2 strand of six mammals (Table S1), 
and one non-mammalian vertebrate (the frog, Xenopus tropicalis; Joint Genome 
Institute Assembly 4.1) were aligned starting with the codon antisense to the stop 
codon for Rev-erbα. (boxed) and extend to the Rev-erbα 3′ss (3′ss arrow). 
Synonymous substitutions in frog relative to the mammalian consensus are indicated 
with an “S”, non-synonymous substitutions with an asterisk. Double-headed arrows 
shown positions of G100, R100 and R42F and R28D′ sequences similar to those in 
Figure 7D. B. Distribution of amino acid substitutions in final exon of Rev-erbα. The 
sequence shown in Panel A is translated for the Rev-erbα antisense strand. Six 
mammals are represented: the sequence shown for rat Rev-erbα is identical to that of 
mouse, cow and dog; human is identical to chimpanzee. The G100 fragment extends 
beyond the sequence shown. C. In vitro splicing for 0,1 and 2 h chimeric Dsx-R70 
transcripts derived from the rat TRα2 sequence (αFD′, Fig. 7C) and the homologous 
antisense strand of frog Rev-erbα (xFD′) as indicated schematically at right. Light 
shading indicates rat sequence, dark shading indicates frog sequences and open boxes 
Dsx exons as in Fig. 7B. Percent splicing (%) and standard deviation (SD) are based 
on averages of three independent experiments. 
Interestingly, both the R1 and R2 elements are perfectly 
conserved in X. tropicalis while R3 is altered by a single substitution. 
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Comparison of the splicing enhancer activity of amphibian sequences 
in the Dsx minigene confirmed that the 70 nucleotide frog sequence, 
R70-xFD′, had only 60% activity of the homologous rat R70-αFD′ 
(Figure 8C). However, the frog antisense sequence displayed 
significant activity relative to the ratantisense Rev-erbβ shown in 
Figure 7A. For example, activity of the chimeric fragment xFαD′ 
indicates that the frog xF sequence and the rat αD′ sequences 
complement one another to a significant extent (47% splicing of xFαD′ 
vs. 56% for αFD′; Figure 8C). These results suggest that ancient, 
conserved sequences with the 3′ end of Rev-erbα mRNA provided a 
foundation for the evolution of an exonic splicing enhancer on the 
antisense strand. 
Discussion 
In this study we have identified two splicing enhancers in the 
TRα gene, TR-ISE3, an intronic splicing enhancer, and ESX10, an 
exonic splicing enhancer. Both promote use of the alternative 3′ss for 
the terminal exon of TRα2 mRNA and map within the antisense overlap 
between the 3′ ends TRα2 and Rev-erbα mRNAs. Interestingly, ESX10 
maps entirely within a bidirectional coding sequence that includes 
sequences coding for both TRα2 and Rev-erbα (Figure 1). Thus the 
sequence of this exonic splicing enhancer (ESE) is almost completely 
constrained by the in-phase overlap of codons for the two mRNAs. The 
C-terminal sequence of Rev-erbα includes part of the heme-binding 
pocket which is homologous to the canonical ligand-binding domain 
present in other nuclear receptor proteins. The C-terminus of TRα2 
confers on this receptor an array of distinctive properties including 
site-specific phosphorylation and wide-ranging effects on DNA binding, 
heterodimerization and co-repressor interactions.14, 41, 42 The presence 
of ESX10 within the Rev-erbα-TRα coding overlap demonstrates the 
ability of RNA sequences to encode three layers of information, two 
complementary coding sequences and a splicing regulatory element, 
within a single sequence. 
Identification of TR-ISE3 
The TR-ISE3 intronic splicing enhancer was mapped to the 3′ 
end of the final intron of TRα2 where it appears to act independently of 
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SEα2, another previously described intronic splicing enhancer at the 5′ 
end of the same intron.34 A trivial explanation for these results is that 
the activity of TR-ISE3 is based simply on a non-specific increase in 
intron length. This possibility can be ruled out for several reasons: 
first, the intron in the pErbAΔBS is over 200 nts, much longer than 
that required for efficient splicing;43 second, the ErbAΔBS is efficiently 
spliced when a single nucleotide substitution is made within either the 
5′ or 3′ss (Figure 2B); and third, replacement of the BP fragment of 
pErbAΔBP with a size-matched heterologous fragment in ErbA-H 
(Figure 3B) of the same length yielded very low splicing, comparable 
to that of ErbAΔBS. 
The sequence of TR-ISE3 includes most of the G-rich region (Gn, 
Figure 1B) and a portion of the highly conserved region just upstream 
of the 3′ss polypyrimidine tract. Although the G-rich region (Figures 
1C and and3E)3E) is less well conserved than the splice-site proximal 
portion of TR-ISE3 (Table S1), similar runs of G residues are present in 
many other introns and have been shown to promote alternative and 
constitutive splicing.34, 44 Such sequences are often specifically 
recognized by hnRNP H/F proteins.34, 45–47 Additionally, G-rich MAZ 
elements (consensus sequence G5AG5) affect alternative splicing and 
polyadenylation through transcriptional pausing.48–50 Since the G-rich 
region in TR-ISE3 is also downstream of the TRα1 poly(A) site, it may 
be part of a multifunctional locus that impacts transcription as well as 
processing. 
Characterization of ESX10 
Results presented here demonstrate that the coding sequence of 
TRα2 overlapping that of Rev-erbα includes ESX10, an exonic splicing 
enhancer (ESE) located140–250 nt downstream of the 3′ ss. This 
region accounts for a substantial portion of the splicing activity that is 
abolished by the deletion of the splice site proximal portion of the exon 
in ErbAΔGR (Figure 4). RESCUE analysis38, 40 revealed a provocative 
distribution of three enhancer-related heptanucleotide sequences (R1, 
R2 and R3) across a 70 nucleotide region within R100 (Figure 7D). 
Substitution of three nucleotides in R1 alone results in a loss of almost 
75 % of splicing activity. While substitutions within R2 and R3 
individually result in only modest decrease in splicing, the combination 
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of five substitutions within these two closely spaced heptamers 
decreases splicing activity by about 40% suggesting that R2 and R3 
together constitute a single functional subelement, R2/R3, of the 
ESX10 enhancer. Substitutions within all three elements decrease 
splicing activity by >95% (Figure 7A). These results suggest a 
hierarchy of interacting enhancer elements within the R100 fragment 
that act synergistically to promote TRα2 splicing. The non-overlapping 
fragment R42αA is also active in heterologous splicing assays (Fig. 6). 
Thus ESX10 is a complex ESE comprised of at least three active 
subelements mapping to sites at R1, R2/R3 and R42A. 
Another bioinformatic approach for identifying exonic splicing 
enhancers involves analysis of consensus binding sites for SR proteins, 
often associated with ESEs, as implement in the program ESEfinder.37, 
39, 51 ESEfinder revealed a large number of candidate binding sites for 
SR proteins SF2/ASF, SC35, SRp55 and SRp75 within the R100 region 
of ESX10 (results not shown) with SC35, SRp 40 and SF2/ASF (SFRS1) 
associated with sites R1, R2 and R3, respectively. In contrast, far 
fewer sites are present within the homologous region of the antisense 
Rev-erbβ strand. However, substitutions in R1 that reduced splicing 
activity had little effect on the ESEfinder score for SC35 binding at this 
site. Thus further biochemical studies are required to determine the 
array of proteins and other factors interacting with ESX10. 
Co-evolution of TRα2 splicing and ESX 10 
Most ESEs map within coding exons of mRNAs52, 53 where the 
dual constraints introduced by requirements for coding and splicing are 
discernible in the statistical bias of synonymous mutations near the 
ends of exons adjacent to splice sites.7, 31, 54, 55 The location of ESX10 
within the coding sequences for both TRα2 and Rev-erbα shows that 
this region simultaneously accommodates at least three layers of 
specific information and illustrates the surprising capacity of the 
genetic code to accommodate additional information as recently 
described by Itzkovitz and Alon.56, 57 The high level of sequence 
conservation and the presence of numerous functional constraints 
make it possible to map the evolutionary history of this locus in detail 
to reconstruct the evolutionary process by which information required 
for TRα2 splicing and coding has been superimposed on Rev-erbα 
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coding sequence. Although Rev-erbα but not TRα is present in model 
organisms such as flies and nematodes, detailed phylogenetic analysis 
indicate that homologs of both nuclear receptor proteins were present 
in the urbilaterian ancestor more than 540 MYA.58, 59 In addition, the 
convergent orientation of TRα and Rev-erbα is conserved among many 
non-mammalian vertebrates (e.g. fish and amphibians), which lack 
TRα2, as well as in the more distantly related and non-overlapping TRβ 
and Rev-erbβ genes. These observations strongly suggest that the 
proximity and orientation of these genes have ancient functions 
independent of TRα2 expression. 
In the genome of the frog X. tropicalis coding sequences of 
TRα1 and Rev-erbα are situated 15 kb apart (vs. only 3.6 kb in 
mammals) and no sequences corresponding to TRα2 are present, 
consistent with TRα2 being a recent evolutionary innovation specific to 
mammals.33 Since the C-termini of Rev-erbα and Rev-erbβ are tightly 
conserved in vertebrates, only a limited number of changes are 
associated with the appearance of TRα2 in the mammalian lineage. 
Within the R100 fragment the frequency of non-synonymous 
substitution is 10-fold higher (0.17 substitutions/nt) than in the rest of 
the BCS, while the occurrence of synonymous substitutions is 
relatively constant throughout. The clustering of non-synonymous 
substitutions in R100 maximizes the number of base changes for a 
given number of amino acid replacements. These changes are 
sufficient to overlay information for splicing enhancement on the 
coding sequences for both Rev-erbα and TRα2. The evolution of TRα2 
is likely to have been facilitated by the presence of such sequences 
compatible with ESX10 activity as evident in the conservation of both 
R1 and R2 on the antisense strand of Rev-erbα in X. tropicalis (Fig. 
8A) but not that of the more distantly related Rev-erbβ (Fig. 7D). 
Consistent with this hypothesis, the X. tropicalis R1 sequence is able to 
activate splicing of a Dsx chimera that includes R2 and R3 from rat 
(compare αFD′ and xFαD′ in Figure 8C). This analysis suggests that 
initial steps in the evolution of TRα2 may require only the evolution of 
a marginally efficient 3′ss sequence on the antisense strand of the 
Rev-erbα 3′ UTR. This scenario is consistent with general requirements 
for the evolution of alternatively spliced exons in many other genes.32, 
60 According to this model, the amino acid sequence of TRα2 and an 
increasingly efficient splicing enhancer (ESX10) may then have 
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coevolved after establishment of an inefficiently spliced TRα2 terminal 
exon, antisense to Rev-erbα. 
Role of antisense overlap in regulating TRα expression 
Antisense transcription is widespread in mammalian genomes4, 
12, 13, 42, 61–63 The convergent overlap orientation observed for TRα2 and 
Rev-erbα mRNAs is the most frequently observed arrangement for 
overlapping mRNAs12, 62 although a coding-coding overlap is less 
common, representing only 10% of overlapping genes.64 Several lines 
of evidence support a role for Rev-erbα expression in repressing TRα2 
splicing: antisense RNA from the 3′ end of Rev-erbα efficiently blocks 
splicing in vitro, and increase in Rev-erbα mRNA expression is 
associated with a decrease in the expression of TRα2 mRNA relative to 
TRα1 in vivo in various cells types.25–28 
The presence of multiple splicing enhancer elements within the 
overlap region (Figure 1) suggests several specific possible 
mechanisms for antisense regulation. For example, base-pairing within 
Rev-erbα and TRα2 mRNA may block binding of splicing factors as 
suggested by previous in vitro experiments26 and the proximity of TR-
ISE3 the 3′ end of the complementary Rev-erbα mRNA may be 
important for initiating base-pairing as shown in prokaryotes.65 
However, mechanisms associated with antisense RNA are very diverse, 
involving both transcriptional and post-transcriptional regulation and 
including positive as well as negative effects on target expression.5, 66–
68 
Since both TRα and Rev-erbα regulate many aspects of 
mammalian development and physiology, it is not surprising that their 
expression and function is regulated at many levels.42, 69- 71 Over the 
past several decades it has become evident that gene expression is 
regulated by many different processes that are often closely linked.4, 72, 
73 The evolution of regulatory elements within regions containing 
multiple layers of genetic information, as demonstrated here for 
ESX10, may prove a common theme as our ability to interpret the 
complex information encoded within the mammalian genome 
continues to advance. 
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Materials and Methods 
Plasmid constructs 
Construction of pErbA, pErbAΔBS and pErbAΔXS has been 
previously described.28 pErbAΔBS(5′ss+5G) was constructed by 
swapping the 5′ portion of pCMV-erbAm(5′ss+5G) with wildtype 
sequence of pErbAΔBS. pErbAΔBS(3′ss-3A) was constructed using PCR 
to replace a single nucleotide at the 3′ ss as shown in Figure 2A. 
pErbAΔBD and pErbAΔBP are similar to pErbAΔBS except for the 
addition of fragments defined by Dra I and Pvu II sites, 81 and 160 bp, 
respectively, upstream of the SspI site that marks the 3′ end of the 
ΔBS deletion. pErbAΔBE includes a similar fragment 118 bp in length 
that was constructed via PCR with an upstream end halfway between 
the sites defining pErbAΔBD and pErbAΔBP. ErbAΔXS, pErbAΔXD, 
pErbAΔXE and pErbΔXP include deletions identical to those in 
pErbAΔBS through pErbAΔBP except that each includes a 250 bp 
Bsu36I/XbaI fragment at the 5′ end of the deletion marked by the 
Bsu36I site. Deletions were constructed in exon 10 of pErbAΔBE as 
follows: pErbAΔGM was created by digesting pErbAΔBE with BsrGI and 
PflMI, Klenow endfilling and ligating; pErbAΔGR was made from 
pErbAΔBE by introducing a deletion between the unique BsrGI site and 
the EcoRI site in exon 10; finally, pErbAΔRM was constructed in a 
similar way by deleting sequences between the same EcoRI site and a 
PflMI site 220 bp downstream in exon 10. The replacement of the 
BsrGI-EcoRI fragment with the corresponding antisense Rev-erbβ 
fragment was achieved by cloning a cDNA copy of the human Rev-erbβ 
gene into these sites in pErbAΔBE. 
pDsx constructs were created from pDsx/KX as previously 
described.34, 35, 74 pDsxGR has a 200 nt PCR fragment copied from the 
BsrGI/EcorI fragment in exon 10 of TRα2 inserted between the KpnI 
and Xba I site of pDsx/KX. This fragment was created with pErbA as a 
template using a reverse primer that included EcoRI and XbaI sites 
matching those in the vector at its 5′ end and a forward primer with 
BsrGI and KpnI sites at its 5′ end. The PCR fragment and Dsx vector 
were cut with KpnI and XbaI and ligated. pDsxR100 was created using 
the EcoRI/XbaI primer described above and a second primer with a 
KpnI site adjacent to the site at the center of the GR fragment. 
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pDsxG100 was created in a similar manner, using the forward primer 
with BsrGI and KpnI sites added and a reverse primer with XbaI site 
complement to sequences adjacent to the start of R100. Dsx 
constructs containing extensions shorter than those associated with 
R100 or G100 were prepared as PCR products using pDsx-derived 
plasmids as templates with a forward primer upstream of the T7 
promoter and a reverse primer with the desired wildtype or mutant 
sequences as shown in Table S2. All plasmids generated by PCR were 
sequenced. Further information on the sequence of all plasmids is 
available on request. 
Plasmid transfection, transcription and in vitro splicing 
pErbA plasmids were transfected into HEK 293 cells via calcium 
phosphate-mediated transfection as described.27 32P-labeled RNA 
transcripts were synthesized from either linearized plasmids or PCR 
templates containing a bacteriophage promoter as previously 
described.34, 75 Templates for the pDsx/KX-ESX10 transcripts were 
linearized with XbaI, pDsx-ASLV was linearized with MluI and pDsx 
with BamHI. In vitro splicing was carried out as previously 
described.26, 34, 36 To start each reaction HeLa cell nuclear extract was 
added to a solution containing the 32P-UTP labeled transcripts. The 
reaction was stopped at the times indicated and the products were run 
on a 5.5% polyacrylamide gel. 
To determine the ratio of TRα1/TRα2 mRNA, a 32P-labeled probe 
that overlaps the TRα2 5′ splice site was used in the RNase protection 
assay as described.27, 34 The probe covers 162 nt at the 3′ most 
portion of TRα1 or 135 nt complementary to exon 9A of TRα2 mRNA. 
Following electrophoresis, gels were scanned with an Ambis 
radioanalytic scanner or Storm phosphoimager. Counts from each 
band were corrected for uridine content in calculating the percent 
splicing.26, 34 
Supplementary Material 
S1 Table S1: Conservation of the overlap between TRα2 and Rev-erbα 
mRNAs. Crosstables for pairwise comparison regions of overlap shown in 
Figure 1. Lengths of regions refer to the genomic sequence of the rat 
(NW_047339) and vary slightly between genomes. Two crosstables are shown 
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for the 3′ end of TRα1 mRNA (TRα1 3′UTR in Fig. 1C) since the chimpanzee 
sequence (NW_001226923) includes only the final 116 bp. The bidirectional 
coding sequence is 200 bp within the exon-exon overlap, while intron 7 of 
Rev-erbα mRNA overlaps with 46 bp of TRα2 coding sequence and 470 bp of 
the TRα2 3′ UTR. Other sequences in the alignment are NT_010755 (human), 
NT_165773 (mouse), NW_876332 (dog) and NW_001493677 11. Positions of 
the TRα1, TRα2 and Rev-erbα poly(A) sites are based on RNase protection 
mapping and cDNA sequences.19, 28 
Table S1: Identity within the region of overlap between TRα2 and Rev-erbα mRNAs 
      
 3'end TRa1(205 BP)      
 DOG RAT MOUSE HUMAN  
COW 96 96 96 97  
DOG  96 96 98  
RAT   99 98  
MOUSE    98  
      
3' end of TRa1 ( 116 bp including Chimp)      
 DOG RAT MOUSE HUMAN CHIMP 
COW 100 100 100 100 100 
DOG  100 100 100 100 
RAT   100 100 100 
MOUSE    100 100 
HUMAN     100 
      
C-rich (140 BP)      
 DOG RAT MOUSE HUMAN CHIMP 
COW 96 89 87 93 94 
DOG  90 89 97 96 
RAT   96 94 93 
MOUSE    92 91 
HUMAN     100 
      
Rev-erba poly(A) proximal region (70 BP)      
 DOG RAT MOUSE HUMAN CHIMP 
COW 97 91 94 96 96 
DOG  94 97 98 98 
RAT   97 96 96 
MOUSE    98 98 
HUMAN     100 
      
G-rich Region (78 BP)      
 DOG RAT MOUSE HUMAN CHIMP 
COW 85 73 74 76 78 
DOG  80 80 80 80 
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RAT   96 77 77 
MOUSE    76 76 
HUMAN     99 
      
      
Conserved region upstream of TRa2 3'ss 
(99 BP)      
 DOG RAT MOUSE HUMAN CHIMP 
COW 99 99 99 99 99 
DOG  98 98 98 98 
RAT   100 100 100 
MOUSE    100 100 
HUMAN     100 
      
Exon-Exon Overlap of TRa2 and Rev-erba mRNA 
(163 BP)      
 DOG RAT MOUSE HUMAN CHIMP 
COW 98 99 99 98 98 
DOG  99 99 99 99 
RAT   100 99 99 
MOUSE    99 99 
HUMAN     100 
      
Intron 7 of Rev-erba mRNA (620 BP)      
 DOG RAT MOUSE HUMAN CHIMP 
COW 86 83 81 86 86 
DOG  83 83 90 90 
RAT   94 85 86 
MOUSE    84 85 
HUMAN     99 
      
Exon 7 of Rev-erba (211 bp)      
 DOG RAT MOUSE HUMAN CHIMP 
COW 95 93 95 96 96 
DOG  90 93 94 94 
RAT   94 93 93 
MOUSE    95 95 
HUMAN     100 
      
S2 Table S2: Primers used for construction of plasmids and transcription 
templates. Forward (F) and reverse (R) orientations of the primers are 
indicated. The primers for the Dsx-R42 templates include an overlap with the 
exon 4 of dsx mRNA at their 3′ end. The reverse primers for R100 and R42A 
Dsx constructs include at their 5′ end an EcoRI site that is not conserved in 
Rev-erbα. 
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Table S2:  Primers used for plasmids constructions.  
   
Description of 
plasmid construct Direction Sequence (5' to 3') 
pErbADXE F AGCTCTAGAGGGGCCAGAGGAGGGTG 
pErbADXE R CATGGACGTAGTGGCCGGACT 
pErbADBS(3'ss-
3C) F GCTTTTCCTTTCGTCTCGTACAGGAG 
pErbADBS(3'ss-
3C) R 
ACGAAAAGGAAAAGCAAAGGAAAAGGTTAGTAATATTG
TTATAA 
pDsx (upstream 
primer) F CGGCCAGTGAATTGTAATACG 
pDsx/KX-R100 F CGGGTACCGCTTGAGCAGCAGTTTGGTG 
pDsx/KX-G100 R GGCTCTAGATGCCGGACCTGCGGACCCTG 
pDsx/KX-GR and 
pDsx/KX-R100 R GGCTCTAGAGAATTCCGCTTCGGTGGAGC 
pDsx/KX-GR and 
pDsx/KX-G100  F CGGGTACCTGTACAAGGGGGCAGCGGCAG 
Dsx/KX-R42aA R 
CTAGA GAA TTCCGCTTCG GTGGAGCAGC 
TCCAGGAGAC GCTGCTGCGG 
TACCGCGATCCAAGCTTATC 
Dsx/KX-R42aB R 
CTAGA GGAGCAGC TCCAGGAGAC GCTGCTGCGG 
GCTCTTCGGG CTCT TACCGCGATCCAAGCTTATC 
Dsx/KX-R42aC R 
CTAGA  AGAC GCTGCTGCGG GCTCTTCGGG 
CTCTGGTGCT GAAGAACC 
TACCGCGATCCAAGCTTATC 
Dsx/KX-R42aD R 
CTAGA GCTCTTCGGG CTCTGGTGCT GAAGAACCGG 
CCCTCGGAGA CT TACCGCGATCCAAGCTTATC 
Dsx/KX-R42aE R 
CTAGA GGTGCT GAAGAACCGG CCCTCGGAGA 
CTTCCCGCTT CACCAA TACCGCGATCCAAGCTTATC 
Dsx/KX-R42aF R 
CTAGA GG CCCTCGGAGA CTTCCCGCTT 
CACCAAACTG CTGCTCAAGC 
TACCGCGATCCAAGCTTATC 
Dsx/KX-R42bA R 
CTAGA GAA TTC CAACTCT GTGGAGGCTT 
TGCAGGAAAC TCTCATTCGT 
TACCGCGATCCAAGCTTAT 
Dsx/KX-R42bB R 
CTAGA GGAGCAGC TCCAGGAGAC GCTGCTGCGG 
GCTCTTCGGG CTCT TACCGCGATCCAAGCTTATC 
Dsx/KX-R42bC R 
CTAGA  AAAC TCTCATTCGT GCACTAAGGA 
CCTTAATAAT GAAAAACC TACCGCGATCCAAGCTTATC 
Dsx/KX-R42bD R 
CTAGA GCACTAAGGA CCTTAATAAT GAAAAACCAT 
CCAAATGAGG CC TACCGCGATCCAAGCTTATC 
Dsx/KX-R42bE R 
CTAGA AATAAT GAAAAACCAT CCAAATGAGG 
CCTCTATTTT TACAAA TACCGCGATCCAAGCTTATC 
Dsx/KX-R42bF R 
CTAGA AT CCAAATGAGG CCTCTATTTT TACAAAACTG 
CTTCTAAAGT TACCGCGATCCAAGCTTATC 
Dsx/KX-R70aFD' R CTAGAGCTCTTCGGGCTCTGGTGCTG 
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Dsx/KX-R70aFbD' R 
CTAGA GCA CTA AGG ACC TTA ATA ATG AAA AAC 
CGG CCC TCG GAG ACT TCC CG 
Dsx/KX-R70bFaD' R 
CTAGA GCT CTT CGG GCT CTG GTG CTG AAG AAC 
CAT CCA AAT GAG GCC TCT AT 
Dsx/KX-R70bFD' R CTAGA GCA CTA AGG ACC TTA ATA ATG 
Dsx/KX-
R42aFD5(3'XbaI) R 
GGCCCTCGGAGACTTCCCGCTTCACCAAACTGCTGCTC
AAGCTACCGCGATCCAAGCTTATC 
Dsx/KX-
R42aFD12(3') R 
CTAGACCTTCCCGCTTCACCAAACTGCTGCTCAAGCTAC
CGCGATCCAAGCTTATC 
Dsx/KX-
R42aFD12(5') R 
CTAGAGGCCCTCGGAGACTTCCCGCTTCACCAAACTAC
CGCGATCCAAGCTTATC 
Dsx/KX-
R70aFD'(R123) R 
CTA GA GCAC TAA GGG CTC TGG TGA TGA AAA ACC 
GGC CCT CGG AGA CTT CCC t  
Dsx/KX-
R70aFD'(R12) R 
CTAGA  GCTCTTC GGGCTCT GGTGaTG AAaAACC 
GGCCCTC GGAGACT TCCCt 
Dsx/KX-
R70aFD'(R13) R 
CTAGA  GCACTAA GGGCTC TGG TGC TGA AGA ACC 
GGC CCT CGG AGA CTT CCC t 
Dsx/KX-
R70aFD'(R23) R 
CTAGA  GCaCTaa GGGCTCT GGTGaTG AAaAACC 
GGCCCTC GGAGACT TC 
R70 aFD(R1) R 
CTAGA 
GCTCTTCGGGCTCTGGTGCTGAAGAACCGGCCCTCGA
GACTTCCC T  
R70 aFD(R2) R 
CTAGA  GCTCTTC GGGCTCT GGTGaTG AAaAACC 
GGCCCTC GGAGACT TC 
R70 aFD(R3) R CTA GAG CAC TAA GGG CTC TGG TGC TGA AGA AC  
R70xFD' R 
CTAGA GCc CTT CGtt CcC T ca TcC TGA AGA Aca Gt 
Cca aac Gat A Cc  TCC CGC 
R70xFaD' R 
CTAGA GC TCT TCG GGC TCT GG TGC TGA AGA ACC  
Gt Cca aac GAt ACc TCC CGC  
R70aFxD' R 
CTAGA GC cCT TCG ttCcC T ca TcC TGA AGA Aca GG 
CCC TC GGA GAC TTC  CCGCT 
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Abbreviations used 
T3 thyroid hormone 
TRα α-thyroid hormone receptor 
3′ss 3′ splice site 
5′ss 5′ splice site 
nt nucleotides 
bp base pairs 
kb kilo base pairs 
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BCS bi-directional coding sequence 
ESE exonic splicing enhancer 
ISE intronic splicing enhancer 
References 
1. Black DL. Mechanisms of alternative pre-messenger RNA splicing. 
Annu Rev Biochem. 2003;72:291–336. 
2. Munroe SH. Diversity of antisense regulation in eukaryotes: multiple 
mechanisms, emerging patterns. J Cell Biochem. 2004;93:664–
71. 
3. Lavorgna G, Dahary D, Lehner B, Sorek R, Sanderson CM, Casari G. 
In search of antisense. Trends Biochem Sci. 2004;29:88–94. 
4. Kapranov P, Willingham AT, Gingeras TR. Genome-wide 
transcription and the implications for genomic organization. Nat 
Rev Genet. 2007;8:413–23. 
5. Munroe SH, Zhu J. Overlapping transcripts, double-stranded RNA 
and antisense regulation: a genomic perspective. Cell Mol Life 
Sci. 2006;63:2102–18. 
6. Hastings ML, Krainer AR. Pre-mRNA splicing in the new millennium. 
Curr Opin Cell Biol. 2001;13:302–9. 
7. Matlin AJ, Clark F, Smith CW. Understanding alternative splicing: 
towards a cellular code. Nat Rev Mol Cell Biol. 2005;6:386–98. 
8. Gustincich S, Sandelin A, Plessy C, Katayama S, Simone R, 
Lazarevic D, et al. The complexity of the mammalian 
transcriptome. J Physiol. 2006;575:321–32. 
9. Modrek B, Lee C. A genomic view of alternative splicing. Nat Genet. 
2002;30:13–9. 
10. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et 
al. Alternative isoform regulation in human tissue 
transcriptomes. Nature. 2008;456:470–6. 
11. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of 
alternative splicing complexity in the human transcriptome by 
high-throughput sequencing. Nat Genet. 2008;40:1413–5. 
12. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, 
Nakamura M, et al. Antisense transcription in the mammalian 
transcriptome. Science. 2005;309:1564–6. 
13. He Y, Vogelstein B, Velculescu VE, Papadopoulos N, Kinzler KW. 
The antisense transcriptomes of human cells. Science. 
2008;322:1855–7. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been 
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis. 
30 
 
14. Lazar MA. Thyroid hormone receptors: multiple forms, multiple 
possibilities. Endocr Rev. 1993;14:184–93. 
15. Committee on Nuclear Receptor Nomenclature. A unified 
nomenclature system for the nuclear receptor superfamily. Cell. 
1999;97:161–3. 
16. Tagami T, Kopp P, Johnson W, Arseven OK, Jameson JL. The 
thyroid hormone receptor variant alpha2 is a weak antagonist 
because it is deficient in interactions with nuclear receptor 
corepressors. Endocrinology. 1998;139:2535–44. 
17. Strait KA, Schwartz HL, Perez-Castillo A, Oppenheimer JH. 
Relationship of c-erbA mRNA content to tissue triiodothyronine 
nuclear binding capacity and function in developing and adult 
rats. J Biol Chem. 1990;265:10514–21. 
18. Keijzer R, Blommaart PJ, Labruyere WT, Vermeulen JL, Doulabi BZ, 
Bakker O, et al. Expression of thyroid hormone receptors A and 
B in developing rat tissues; evidence for extensive 
posttranscriptional regulation. J Mol Endocrinol. 2007;38:523–
35. 
19. Lazar MA, Hodin RA, Darling DS, Chin WW. A novel member of the 
thyroid/steroid hormone receptor family is encoded by the 
opposite strand of the rat c-erbA alpha transcriptional unit. Mol 
Cell Biol. 1989;9:1128–36. 
20. Miyajima N, Horiuchi R, Shibuya Y, Fukushige S, Matsubara K, 
Toyoshima K, et al. Two erbA homologs encoding proteins with 
different T3 binding capacities are transcribed from opposite 
DNA strands of the same genetic locus. Cell. 1989;57:31–9. 
21. Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, et al. 
Rev-erbalpha, a heme sensor that coordinates metabolic and 
circadian pathways. Science. 2007;318:1786–9. 
22. Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure 
DB, et al. Identification of heme as the ligand for the orphan 
nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct 
Mol Biol. 2007;14:1207–13. 
23. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, 
Albrecht U, et al. The orphan nuclear receptor REV-ERBalpha 
controls circadian transcription within the positive limb of the 
mammalian circadian oscillator. Cell. 2002;110:251–60. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been 
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis. 
31 
 
24. Pardee KI, Xu X, Reinking J, Schuetz A, Dong A, Liu S, et al. The 
structural basis of gas-responsive transcription by the human 
nuclear hormone receptor REV-ERBbeta. PLoS Biol. 2009;7:e43.  
25. Lazar MA, Hodin RA, Cardona G, Chin WW. Gene expression from 
the c-erbA alpha/Rev-ErbA alpha genomic locus. Potential 
regulation of alternative splicing by opposite strand 
transcription. J Biol Chem. 1990;265:12859–63. 
26. Munroe SH, Lazar MA. Inhibition of c-erbA mRNA splicing by a 
naturally occurring antisense RNA. J Biol Chem. 
1991;266:22083–6. 
27. Hastings ML, Milcarek C, Martincic K, Peterson ML, Munroe SH. 
Expression of the thyroid hormone receptor gene, erbAalpha, in 
B lymphocytes: alternative mRNA processing is independent of 
differentiation but correlates with antisense RNA levels. Nucleic 
Acids Res. 1997;25:4296–300. 
28. Hastings ML, Ingle HA, Lazar MA, Munroe SH. Post-transcriptional 
regulation of thyroid hormone receptor expression by cis-acting 
sequences and a naturally occurring antisense RNA. J Biol 
Chem. 2000;275:11507–13. 
29. Chamary JV, Parmley JL, Hurst LD. Hearing silence: non-neutral 
evolution at synonymous sites in mammals. Nat Rev Genet. 
2006;7:98–108. 
30. Warnecke T, Parmley JL, Hurst LD. Finding exonic islands in a sea 
of non-coding sequence: splicing related constraints on protein 
composition and evolution are common in intron-rich genomes. 
Genome Biol. 2008;9:R29. 
31. Willie E, Majewski J. Evidence for codon bias selection at the pre-
mRNA level in eukaryotes. Trends Genet. 2004;20:534–8. 
32. Xing Y, Lee C. Alternative splicing and RNA selection pressure--
evolutionary consequences for eukaryotic genomes. Nat Rev 
Genet. 2006;7:499–509. 
33. Forrest D, Sjoberg M, Vennstrom B. Contrasting developmental 
and tissue-specific expression of alpha and beta thyroid 
hormone receptor genes. EMBO J. 1990;9:1519–28. 
34. Hastings ML, Wilson CM, Munroe SH. A purine-rich intronic element 
enhances alternative splicing of thyroid hormone receptor 
mRNA. RNA. 2001;7:859–74. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been 
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis. 
32 
 
35. Tanaka K, Watakabe A, Shimura Y. Polypurine sequences within a 
downstream exon function as a splicing enhancer. Mol Cell Biol. 
1994;14:1347–54.  
36. Tian M, Maniatis T. A splicing enhancer complex controls 
alternative splicing of doublesex pre-mRNA. Cell. 1993;74:105–
14. 
37. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: A 
web resource to identify exonic splicing enhancers. Nucleic Acids 
Res. 2003;31:3568–71. 
38. Fairbrother WG, Yeh RF, Sharp PA, Burge CB. Predictive 
identification of exonic splicing enhancers in human genes. 
Science. 2002;297:1007–13. 
39. Liu HX, Zhang M, Krainer AR. Identification of functional exonic 
splicing enhancer motifs recognized by individual SR proteins. 
Genes Dev. 1998;12:1998–2012. 
40. Fairbrother WG, Yeo GW, Yeh R, Goldstein P, Mawson M, Sharp PA, 
et al. RESCUE-ESE identifies candidate exonic splicing enhancers 
in vertebrate exons. Nucleic Acids Res. 2004;32:W187–90.  
41. Katz D, Lazar MA. Dominant negative activity of an endogenous 
thyroid hormone receptor variant (alpha 2) is due to competition 
for binding sites on target genes. J Biol Chem. 
1993;268:20904–10. 
42. Engstrom PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna 
G, et al. Complex Loci in human and mouse genomes. PLoS 
Genet. 2006;2:e47. 
43. Green MR. Pre-mRNA splicing. Annu Rev Genet. 1986;20:671–
708. 
44. McCullough AJ, Berget SM. G triplets located throughout a class of 
small vertebrate introns enforce intron borders and regulate 
splice site selection. Mol Cell Biol. 1997;17:4562–71. 
45. Caputi M, Zahler AM. Determination of the RNA binding specificity 
of the heter ogeneous nuclear ribonucleoprotein (hnRNP) 
H/H′/F/2H9 family. J Biol Chem. 2001;276:43850–9. 
46. Han K, Yeo G, An P, Burge CB, Grabowski PJ. A combinatorial code 
for splicing silencing: UAGG and GGGG motifs. PLoS Biol. 
2005;3:e158. 
47. Martinez-Contreras R, Fisette JF, Nasim FU, Madden R, Cordeau M, 
Chabot B. Intronic binding sites for hnRNP A/B and hnRNP F/H 
proteins stimulate pre-mRNA splicing. PLoS Biol. 2006;4:e21.  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been 
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis. 
33 
 
48. Ashfield R, Patel AJ, Bossone SA, Brown H, Campbell RD, Marcu 
KB, et al. MAZ-dependent termination between closely spaced 
human complement genes. EMBO J. 1994;13:5656–67. 
49. Robson-Dixon ND, Garcia-Blanco MA. MAZ elements alter 
transcription elongation and silencing of the fibroblast growth 
factor receptor 2 exon IIIb. J Biol Chem. 2004;279:29075–84. 
50. Roberts GC, Gooding C, Mak HY, Proudfoot NJ, Smith CW. Co-
transcriptional commitment to alternative splice site selection. 
Nucleic Acids Res. 1998;26:5568–72. 
51. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR. An 
increased specificity score matrix for the prediction of SF2/ASF-
specific exonic splicing enhancers. Hum Mol Genet. 
2006;15:2490–508. 
52. Mayeda A, Screaton GR, Chandler SD, Fu XD, Krainer AR. 
Substrate specificities of SR proteins in constitutive splicing are 
determined by their RNA recognition motifs and composite pre-
mRNA exonic elements. Mol Cell Biol. 1999;19:1853–63.  
53. Schaal TD, Maniatis T. Multiple distinct splicing enhancers in the 
protein-coding sequences of a constitutively spliced pre-mRNA. 
Mol Cell Biol. 1999;19:261–73. 
54. Cartegni L, Chew SL, Krainer AR. Listening to silence and 
understanding nonsense: exonic mutations that affect splicing. 
Nat Rev Genet. 2002;3:285–98. 
55. Parmley JL, Chamary JV, Hurst LD. Evidence for purifying selection 
against synonymous mutations in mammalian exonic splicing 
enhancers. Mol Biol Evol. 2006;23:301–9. 
56. Itzkovitz S, Alon U. The genetic code is nearly optimal for allowing 
additional information within protein-coding sequences. Genome 
Res. 2007;17:405–12. 
57. Bollenbach T, Vetsigian K, Kishony R. Evolution and multilevel 
optimization of the genetic code. Genome Res. 2007;17:401–4. 
58. Escriva H, Bertrand S, Laudet V. The evolution of the nuclear 
receptor superfamily. Essays Biochem. 2004;40:11–26. 
59. Segraves WA, Hogness DS. The E75 ecdysone-inducible gene 
responsible for the 75B early puff in Drosophila encodes two 
new members of the steroid receptor superfamily. Genes Dev. 
1990;4:204–19. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been 
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis. 
34 
 
60. Xiao X, Wang Z, Jang M, Burge CB. Coevolutionary networks of 
splicing cis-regulatory elements. Proc Natl Acad Sci U S A. 
2007;104:18583–8. 
61. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa 
D, et al. Unbiased mapping of transcription factor binding sites 
along human chromosomes 21 and 22 points to widespread 
regulation of noncoding RNAs. Cell. 2004;116:499–509. 
62. Chen J, Sun M, Kent WJ, Huang X, Xie H, Wang W, et al. Over 
20% of human transcripts might form sense-antisense pairs. 
Nucleic Acids Res. 2004;32:4812–20. 
63. Kiyosawa H, Mise N, Iwase S, Hayashizaki Y, Abe K. Disclosing 
hidden transcripts: mouse natural sense-antisense transcripts 
tend to be poly(A) negative and nuclear localized. Genome Res. 
2005;15:463–74. 
64. Veeramachaneni V, Makalowski W, Galdzicki M, Sood R, 
Makalowska I. Mammalian overlapping genes: the comparative 
perspective. Genome Res. 2004;14:280–6.  
65. Nordstrom K, Wagner EG. Kinetic aspects of control of plasmid 
replication by antisense RNA. Trends Biochem Sci. 
1994;19:294–300. 
66. Shearwin KE, Callen BP, Egan JB. Transcriptional interference--a 
crash course. Trends Genet. 2005;21:339–45. 
67. Beiter T, Reich E, Williams RW, Simon P. Antisense transcription: a 
critical look in both directions. Cell Mol Life Sci. 2009;66:94–
112. 
68. Mahmoudi S, Henriksson S, Corcoran M, Mendez-Vidal C, Wiman 
KG, Farnebo M. Wrap53, a natural p53 antisense transcript 
required for p53 induction upon DNA damage. Mol Cell. 
2009;33:462–71. 
69. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf 
DJ. Anatomical profiling of nuclear receptor expression reveals a 
hierarchical transcriptional network. Cell. 2006;126:789–99. 
70. Burris TP. Nuclear hormone receptors for heme: REV-ERBalpha 
and REV-ERBbeta are ligand-regulated components of the 
mammalian clock. Mol Endocrinol. 2008;22:1509–20. 
71. Flamant F, Samarut J. Thyroid hormone receptors: lessons from 
knockout and knock-in mutant mice. Trends Endocrinol Metab. 
2003;14:85–90. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been 
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis. 
35 
 
72. Darnell JE., Jr Variety in the level of gene control in eukaryotic 
cells. Nature. 1982;297:365–71. 
73. Bartel DP, Chen CZ. Micromanagers of gene expression: the 
potentially widespread influence of metazoan microRNAs. Nat 
Rev Genet. 2004;5:396–400. 
74. McNally LM, McNally MT. An RNA splicing enhancer-like sequence is 
a component of a splicing inhibitor element from Rous sarcoma 
virus. Mol Cell Biol. 1998;18:3103–11. 
75. Munroe SH. Antisense RNA inhibits splicing of pre-mRNA in vitro. 
EMBO J. 1988;7:2523–32. 
 
About the Authors: 
Address correspondence to: Stephen H. Munroe, Department of Biological 
Sciences, Wehr Life Sciences Building 109, Marquette University, PO Box 
1881, Milwaukee, WI 53201, Tel: 414-288-1485, FAX: 414-288-7357, Email: 
munores@marquette.edu  
Valerie K. Salato: Current address: Department of Pathology, Medical College 
of Wisconsin, Milwaukee, WI 53226. 
Nathaniel W. Rediske: Current address: School of Medicine, Oregon Health 
and Science University, Portland, OR 97239. 
Michelle L. Hastings: Current address: Department of Cell Biology and 
Anatomy, Chicago Medical School, Rosalind Franklin University of Medicine 
and Science, North Chicago, IL 60064 
